Sign In
Buy SRPT
$16.24
-0.0100 (-0.0615%)
At Close: Jun 03, 2026
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Average Recommendation of “Hold” by Brokerages
01:43am, Wednesday, 17'th Dec 2025
Shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT - Get Free Report) have earned an average rating of "Hold" from the thirty brokerages that are covering the stock, Marketbeat Ratings reports. Six eq
Market Today: Jobs Cool, EU Eases Engine Ban, Oil Hits 2021 Lows
05:36pm, Tuesday, 16'th Dec 2025
Stock News U.S. labor market cools: The U.S. added 64,000 jobs in November after a 105,000 decline in October as unemployment rose to 4.6%, the highest since 20
First Look: iRobot Bankruptcy, Netflix-WBD Fight, Tesla Robotaxi
07:38am, Monday, 15'th Dec 2025
Stock News iRobot enters Chapter 11: iRobot (IRBT) filed for Chapter 11 and agreed to be acquired by contract manufacturer Picea Robotics, saying operations and
Sarepta Therapeutics Announces Refinancing of Approximately $291 Million of 1.25% Convertible Senior Notes due 2027
07:00am, Thursday, 11'th Dec 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately ne
Sarepta Therapeutics, Inc. $SRPT Shares Bought by Federated Hermes Inc.
04:35am, Wednesday, 10'th Dec 2025
Federated Hermes Inc. grew its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 347.8% during the second quarter, according to its most recent Form 13F filing with the Securities and
Wedbush Says Sarepta Selloff “Overdone”
01:52pm, Tuesday, 09'th Dec 2025
Sarepta Therapeutics (SRPT) is getting a fresh vote of confidence from Wedbush, which initiated coverage with an Outperform rating, arguing the stock's selloff
Wedbush Says Sarepta Selloff “Overdone”(edit)
11:59am, Tuesday, 09'th Dec 2025
Sarepta Therapeutics (SRPT) is getting a fresh vote of confidence from Wedbush, which initiated coverage with an Outperform rating, arguing the stock's selloff
Dyne's Duchenne Drug Shows Strong Muscle And Function Improvements
01:37pm, Monday, 08'th Dec 2025
Dyne Therapeutics reported positive results from Phase 1/2 DELIVER trial for z-rostudirsen in DMD amenable to exon 51 skipping.
Edgestream Partners L.P. Purchases 74,427 Shares of Sarepta Therapeutics, Inc. $SRPT
04:11am, Saturday, 06'th Dec 2025
Edgestream Partners L.P. lifted its position in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 870.3% in the second quarter, according to the company in its most recent 13F filing with the Sec
Why Is Sarepta Therapeutics (SRPT) Up 26.4% Since Last Earnings Report?
12:36pm, Wednesday, 03'rd Dec 2025
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock?
Sarepta Therapeutics, Inc. $SRPT Shares Acquired by Commonwealth of Pennsylvania Public School Empls Retrmt SYS
05:04am, Thursday, 27'th Nov 2025
Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 10.6% in the second quarter, according to its most recent F
Envestnet Asset Management Inc. Decreases Stake in Sarepta Therapeutics, Inc. $SRPT
03:58am, Thursday, 27'th Nov 2025
Envestnet Asset Management Inc. lessened its stake in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 33.1% in the second quarter, according to the company in its most recent Form 13F filing wi
Sarepta's Stock Rises on Positive Updates on DM1 Therapy
02:11pm, Tuesday, 25'th Nov 2025
SRPT's stock jumps as its SRP-1003 study advances with a positive safety review and new dosing cohorts underway.
Sarepta Secures FDA Nod For Elevidys Study To Reduce Liver Injury Risk
12:07pm, Tuesday, 25'th Nov 2025
The U.S. Food and Drug Administration (FDA) on Tuesday approved dosing in Sarepta Therapeutics Inc.'s (NASDAQ: SRPT) Cohort 8 of ENDEAVOR (Study 9001-103).
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA
